Adriamycin
Product Images NDC 0143-9275

6 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Adriamycin (NDC 0143-9275). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Adriamycin Doxorubicin HCl For Injection Usp 1)

Structural Formula (Adriamycin Doxorubicin HCl For Injection Usp 1)
Chemical structure diagram of Adriamycin (doxorubicin hydrochloride), depicting the molecular components including rings, hydroxyl groups, and hydrochloride (HCl).*
FDA Label Image

Figure 1 And 2 (Adriamycin Doxorubicin HCl For Injection Usp 2)

Figure 1 And 2 (Adriamycin Doxorubicin HCl For Injection Usp 2)
Two meta-analysis forest plots showing hazard ratios with 95% confidence intervals for trials comparing disease-free survival and overall survival between Doxorubicin-based regimens and CMF regimens. The top plot depicts disease-free survival across six studies, and the bottom plot shows overall survival for the same trials, highlighting comparative treatment effects.*
FDA Label Image

Vial Label For 10 mg/vial (Adriamycin Doxorubicin HCl For Injection Usp 3)

Vial Label For 10 mg/vial (Adriamycin Doxorubicin HCl For Injection Usp 3)
Adriamycin 10 mg/vial lyophilized powder for injection, containing doxorubicin hydrochloride. Single-dose vial packaging with instructions for intravenous use. Labeler is Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Adriamycin (doxorubicin HCl) For Injection Vial Label For 50 mg/vial (Adriamycin Doxorubicin HCl For Injection Usp 4)

Adriamycin (doxorubicin HCl) For Injection Vial Label For 50 mg/vial (Adriamycin Doxorubicin HCl For Injection Usp 4)
Adriamycin (Doxorubicin HCl) injection, 50 mg per vial, sterile and lyophilized for intravenous use only. The single-dose vial is labeled for USP usage with directions for dosage and storage conditions. Manufactured by THYMOORGAN PHARMAZIE GmbH, Germany, and distributed by West-Ward, Eatontown, NJ, USA. The label includes warnings for severe cell lysis, vesication, and tissue necrosis with extravasation and barcode identification.*
FDA Label Image

Representative Carton Serialization Image (Adriamycin Doxorubicin HCl For Injection Usp 5)

Representative Carton Serialization Image (Adriamycin Doxorubicin HCl For Injection Usp 5)
A white label for Adriamycin by Hikma Pharmaceuticals USA Inc. The label includes a datamatrix barcode and printed lot number, expiration date, GTIN, and serial number in black text. No strength or dosage form is visible.*
FDA Label Image

Representative Carton Serialization Image (Adriamycin Doxorubicin HCl For Injection Usp 6)

Representative Carton Serialization Image (Adriamycin Doxorubicin HCl For Injection Usp 6)
The image shows a product label containing a QR code and various product identification numbers. It includes a GTIN (Global Trade Item Number), serial number (SN), expiration date (EXP) formatted as MMYYYY, and lot number. The label corresponds to Adriamycin by Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.